Management of opiate detoxification in jails

Journal of Addictive Diseases

Volumn 24, Issue 1, 2005, Pages 61-71

  Fiscella, Kevin ^a,b   Moore, Andrew ^a   Engerman, Judith ^a   Meldrum, Sean ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b Family Medicine Center Rochester   (United States)

Author keywords

Heroin dependence; Prisoners; Substance withdrawal syndrome

Indexed keywords

CLONIDINE; METHADONE; OPIATE;

ADULT; CLINICAL PROTOCOL; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG DEPENDENCE; DRUG DETOXIFICATION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL EXAMINATION; PRISON; REVIEW; STANDARDIZATION; STATISTICAL SIGNIFICANCE; TECHNIQUE; TREATMENT FAILURE; UNITED STATES;

ACUTE DISEASE; ADRENERGIC ALPHA-AGONISTS; CLONIDINE; HEALTH CARE SURVEYS; HUMANS; METHADONE; NARCOTICS; OPIOID-RELATED DISORDERS; PRISONERS; SUBSTANCE WITHDRAWAL SYNDROME; UNITED STATES;

EID: 13444253814     PISSN: 10550887     EISSN: None     Source Type: Journal    
DOI: 10.1300/J069v24n01_06     Document Type: Review

References (27)

1. Young L. Improving quality and oversight of methadone treatment. SAMHSA NEWS, 1999 (available at http://www.samhsa.gov/press/99/990722fs.htm, accessed 8/10/01).
2. Appel PW, Joseph H, Kott A, Nottingham W, Tasiny E, Habel E. Selected in-treatment outcomes of long-term methadone maintenance treatment patients in New York State. Mt Sinai Med 2001;68:55-61.
3. O'Connor PG, Kosten TR. Management of opioid intoxication and withdrawal. In: Graham AW, Schulz TK, editors. Principles of Addiction Medicine. Chevy Chase: American Society of Addiction Medicine 2000: 457-464.
4. American Psychiatric Association. Practice guideline for the treatment of patients with substance use disorders: Alcohol, cocaine, opioids. Am J Psychiatr 1995;152:Suppl-59.
5. National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction. Effective medical treatment of opiate addiction. JAMA 1998;280:1936-1943.
6. National Commission on Correctional Health Care. Standards for Health Services in Jails. Chicago: National Commission on Correctional Health Care, 1996.
7. Federal Bureau of Prisons. Clinical Practice Guidelines: Detoxification of Chemically Dependent Persons. Washington, DC: National Institute of Corrections, 2000. 1-44.
8. Substance Abuse and Mental Health Services Administration. Substance Abuse Treatment in Adult and Juvenile Correctional Facilities: Findings from the Uniform Facilities Data Set 1997 Survey of Correctional Facilities. Rockville, MD:SAMHSA, Office of Applied Studies, 2000. (available at http://www.samhsa.gov/ oas/UFDS/CorrectionalFacilities97/index.htm, accessed 7/20/01)
9. Dillman DA. Mail and Telephone Surveys: The Total Design Method. New York: John Wiley & Sons, 1978.
10. Stephan JJ. Census of Jails, 1999. Washington, DC, U.S. Department of Justice, August, 2001.
11. National Institute of Justice. Annual Report 2000: Arrestee Drug Abuse Monitoring. Washington, DC, US Department of Justice, 2003.
12. Mayo-Smith MF. Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal JAMA 1997;278:144-151.
13. O'Connor PG, Carroll KM, Shi JM, Schottenfeld RS, Kosten TR, Rounsaville BJ. Three methods of opioid detoxification in a primary care setting. A randomized trial. Ann Intern Med 1997;127:526-530.
14. San L, Cami J, Peri JM, Mata R, Porta M. Efficacy of clonidine, guanfacine and methadone in the rapid detoxification of heroin addicts: A controlled clinical trial. Br J Addict 1990;85:141-147.
15. Armenian SH, Chutuape MA, Stitzer ML. Predictors of discharges against medical advice from a short-term hospital detoxification unit. Drug Alcohol Depend 1999;56:1-8.
16. Ghodse H, Myles J, Smith SE. Clonidine is not a useful adjunct to methadone gradual detoxification in opioid addiction. Br J Psychiatry 1994;165:370-374.
17. Kosten TR, Rounsaville BJ, Kleber HD. Comparison of clinician ratings to self reports of withdrawal during clonidine detoxification of opiate addicts. Am J Drug Alcohol Abuse 1985;11:1-10.
18. Gowing LR, Farrell M, Ali RL, White JM. Alpha2-adrenergic agonists in opioid withdrawal. Addiction 2002;97:49-58.
19. Gowing L, Ali R, White J. Buprenorphine for the management of opioid withdrawal. Cochrane Database of Systematic Reviews 2002;CD002025.
20. McCann MJ, Miotto K, Rawson RA, Huber A, Shoptaw S, Ling W. Outpatient non-opioid detoxification for opioid withdrawal. Who is likely to benefit? Am J Addict 1997;6:218-223.
21. Perkins CA, Stephan JJ, Beck AJ. Jails and Jail Inmates 1993-94 Census of Jails and Survey of Jails. Washington, DC: U.S. Department of Justice Office of Justice Programs. 995 NCJ-151651.
22. Wilson DJ. Drug Use, Testing, and Treatment in Jails. Washington, DC: USGPO, Bureau of Justice Statistics. 2000. NCJ179999. (available at http://www.ojp.usdoj.gov:80/bjs/pub/pdf/duttj.pdf, accessed 8/21/2001)
23. Flanigan P. State hits Monroe in death of inmate. Democrat and Chronicle 2001;1A-7A.
24. Stohr MK, Hemmens C, Kifer M, Schoeler M. We know it, we just have to do it: Perceptions of ethical work in prisons and jails. Prison Journal 2000;80:126-150.
25. Cullen FT, Lutze FE, Link BG, Wolfe NT. The correctional orientation of prison guards: Do officers support rehabilitation? Federal Probation 1989;53:42.
26. Jeanmonod R, Harding T, Staub C. Treatment of opiate withdrawal on entry to prison. Br J Addict 1991;86:457-463.
27. Mattick RP, Kimber J, Breen C, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database of Systematic Reviews 2002;CD002207.